# Effects of Topical Diclofenac on Tumor Metabolism

> **NCT01935531** · PHASE4 · COMPLETED · sponsor: **University Hospital Regensburg** · enrollment: 38 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** 3% diclofenac in 2.5% hyaluronic acid gel

## Key facts

- **NCT ID:** NCT01935531
- **Lead sponsor:** University Hospital Regensburg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01935531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01935531, "Effects of Topical Diclofenac on Tumor Metabolism". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01935531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*